Clinical Trial

Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

Study acronym: CIVIK
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-01 -> 2027-10-01 2026-08-08
minor Completion pushed: 2026-12-01 -> 2027-12-01 2026-08-08
Trial Details
NCT Number NCT04040452
Lead Sponsor Phoenix Children's Hospital
Conditions Congenital Heart Disease in Children
Enrollment 166 participants
Start Date 2021-03-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12